Order Entry
United States
ContactUsLinkComponent
 
BTXpress Cytofusion® Electroporation Medium C, Harvard Apparatus
  MSPP-47-0001
undefined
BTXpress Cytofusion® Electroporation Medium C, Harvard Apparatus
  MSPP-47-0001
 :  47-0001
Restricted Products: To process your orders without delay, please provide the required business documentation to purchase this product.

To order chemicals, medical devices, or other restricted products please provide ID that includes your business name & shipping address via email [email protected] or fax 484.881.5997 referencing your VWR account number. Acceptable forms of ID are:

  • • State issued document with your organization's Federal Tax ID Number
  • • State issued document with your organization's Resale Tax ID Number
  • • City or County issued Business License
  • • State Department of Health Services License
  • • Any other ID issued by the State that includes the business name & address

* ATTN: California Customers may require additional documentation as part of the CA Health & Safety Code. Products that fall under this regulation will be placed on a mandatory 21-day hold after documentation is received. Avantor will not lift restrictions for residential shipping addresses.

 

  • Description:
    BTXpress Cytofusion® Electroporation Medium C
  • Size:
    500 ml
  • Environmentally Preferable:
  • Cat. No.:
    MSPP-47-0001

 

 

BTXpress Cytofusion® Medium C is an advanced electrofusion buffer designed for use with the BTX Hybrimune System for high performance cell fusion applications.

  • Osmolarity: 270 to 290 mOsm/l
  • Conductivity at 25 °C: 0.080 ±0.005 mS/cm
  • pH: 7.2 ±0.2
  • Endotoxin: <0.25 EU/ml

The low conductivity buffer is specially-formulated to minimize cell turbulence during cell alignment and heating during electrofusion for robust cell fusion efficiency and high cell viability. It is sterile filtered from the highest quality non-animal, medical-grade reagents. It is the buffer of choice for many commercial biotech and pharmaceutical companies in their hybridoma generation process for monoclonal antibody discovery.

It is sterile filtered and optimized for eukaryotic electrofusion applications and also has stable environment for cell alignment.